Ardiente, Roselife .

HRN: 22-93-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
AMPICILLIN 1GM (VIAL)
04/17/2023
04/18/2023
IV
2g
Q6
PROM X 6 Hrs
Waiting Final Action 
04/17/2023
CO-AMOXICLAV 625MG (TAB)
04/17/2023
04/24/2023
PO
1 Tab
TID
SP NSVD; 2nd Degree Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: